Chatham Lodging Trust (CLDT) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
2 Mar, 2026Business performance and growth
RevPAR growth outpaced industry for four consecutive years, with FY '24 up 2.8% versus industry 1.8%.
Hotel EBITDA margin of 35.0% is the highest among lodging REITs.
Acquiring $100 million in hotels at a 9% cap rate would boost EBITDA and FFO/share by 12% and 9%, respectively.
$10 million in share repurchases at current prices is 2% accretive to FFO/share.
Sold seven hotels for $119 million since 2024, enhancing portfolio quality and balance sheet.
Revenue and margin leadership
RevPAR growth in 2024 and 2025 exceeded both full-service and limited-service peers.
FY 2025 EBITDA margin projected at 35.0%, leading the industry.
Extended stay and upscale limited-service hotels drive superior margins.
Market and portfolio positioning
Portfolio concentrated in high-quality, attractive markets with top brands.
66% of LTM EBITDA generated by extended stay hotels.
Highest RevPAR among limited-service focused lodging REITs.
Largest concentration of extended stay rooms among lodging REITs at 64%.
Latest events from Chatham Lodging Trust
- Industry-leading margins, reduced leverage, and a return to profitability set the stage for 2026.CLDT
Q4 202527 Feb 2026 - Q2 RevPAR up 4%, Phoenix hotel acquired, and balance sheet strengthened despite higher costs.CLDT
Q2 20242 Feb 2026 - Q3 RevPAR growth, asset sales, and tech market strength support debt reduction and outperformance.CLDT
Q3 202416 Jan 2026 - Q4 RevPAR up 4%, margins expand, and leverage falls as tech markets drive growth.CLDT
Q4 202423 Dec 2025 - Proxy covers trustee elections, auditor ratification, executive pay, and equity plan amendment.CLDT
Proxy Filing2 Dec 2025 - Shareholders will vote on directors, auditor ratification, compensation, and plan amendment.CLDT
Proxy Filing2 Dec 2025 - Board urges approval of Equity Incentive Plan amendment to sustain aligned, cost-effective pay.CLDT
Proxy Filing2 Dec 2025 - Outperforming peers in RevPAR and margins, with strong growth potential from business travel recovery.CLDT
Investor Presentation27 Nov 2025 - Q2 2025 delivered resilient RevPAR, reduced leverage, and robust share repurchases.CLDT
Q2 202523 Nov 2025